echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Cancer Res: E2A regulates the stemness, metastasis and treatment resistance of breast cancer

    Cancer Res: E2A regulates the stemness, metastasis and treatment resistance of breast cancer

    • Last Update: 2021-08-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Cancer stem cells (CSC) are thought to be involved in tumor initiation, treatment resistance and metastasis


    Metastasis and treatment resistance are the main challenges facing current oncology


    The E2A protein (E12/E47) is a member of the basic helix-loop-helix (BHLH) TF family.


    E2A regulates the stemness, metastasis and treatment resistance of breast cancer

    Image source: https://cancerres.


    In order to evaluate the contribution of specific EMT-TF, especially E2A factor, to breast CSC biology, the authors generated conditional E2A knockout mice in the context of the MMTV-PyMT model of BC


    In summary, this study shows that E2A's EMT-TF plays a key role in the stemness of BC, tumor initiation and metastasis, and characterizes a new E2A-Snail1 axis involved in the occurrence and dedifferentiation of breast tumors, and confirms E2A is a vulnerable target in new treatments for BC patients


    references

    Celia López-Menéndez et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.